Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Core Insights - Heartflow, Inc. is a leader in AI technology for coronary artery disease and will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 [1] Company Overview - Heartflow is transforming coronary artery disease management by enabling early detection, accurate diagnosis, and lifelong management [4] - The Heartflow One platform utilizes AI to convert coronary CTA images into personalized 3D heart models, providing actionable insights into plaque characteristics and blood flow without invasive procedures [4] Technology and Research - Heartflow's technology is supported by over 600 peer-reviewed publications and has been adopted by more than 1,400 institutions globally, impacting over 500,000 patients [3] - The company has built a proprietary data pipeline from over 160 million annotated CTA images, powering advanced AI models that deliver accurate insights across diverse patient populations [6] - Heartflow's AI solutions have been validated in over 100 studies involving more than 365,000 patients, achieving coronary CTA image acceptance rates exceeding 97% [6] Clinical Integration and Compliance - Heartflow provides instant, quality-reviewed analyses upon order, facilitating a seamless transition from diagnosis to decision for clinicians [6] - The company adheres to leading international standards for quality systems, global security, and patient-data integrity, including HITRUST, SOC 2 Type 2, ISO 13485, and ISO 27001 [6]